Yoon, Isabel C.
Perez-Rojas, Stephany
Ancha, Bhavya
Elmore, Leisha C.
Mateo, Alina M.
Pichardo, Margaret S.
Tchou, Julia C.
Zhang, Jennifer Q.
Hubbard, Rebecca A.
Fayanju, Oluwadamilola M. https://orcid.org/0000-0002-0876-975X
Article History
First Online: 11 June 2025
Disclosure
: Dr. Fayanju is supported by the National Institutes of Health (NIH) under Award Numbers 7K08CA241390-03 (PI: Fayanju) and P50CA244690 (PI: Schnoll), the Breast Cancer Research Foundation, and philanthropic funds from the Haas family. She also reports research support unrelated to this work from the NIH under Award Number U48DP006801 (PI: Fayanju) and Gilead Sciences, Inc. This work was also supported by the Electronic Phenotyping Resource (EPR) at Abramson Cancer Center under NIH Award Number 2P30CA016520-45 (PI: Vonderheide). The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Dr. Hubbard reports institutional grants from Pfizer and Merck as well as institutional payment for teaching from Johnson & Johnson. None of the other authors has any conflicts of interest to disclose. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.